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Volume 49, Number 5S Poster Presentations 39SResults: VV surgeries were done in 162 limbs of 94 patients (both in
68, right in 18, and left in 8). There were 56 females and 38 males with the
mean age of 57 years (2879). The CEAP classification was C2-3EpAsPr in all
patients. Perforators larger than 2mm near the varicose veins were detected
and marked on the CT volume-rendering images. The average numbers of
perforators marked by CTV were 13.44.22 in each limb. The perforators
were evaluated by duplex for the presence of reflux (0.5 sec). Mean
number of perforators with reflux in one limb was 1.3 1.35, which were
ligated during the surgery. Incidental detections of other disease were done
in 3 patients, including uterine myomas and ovarian cyst. Operation was
performed with the CTV images on screen. CTV was helpful in designing
the operation inmost patients. 3DCTV images of saphenopopliteal junction
especially provided thorough understanding of the complex variable anat-
omy of the lesion. There were no CT-related complications, such as renal
dysfunction or allergic reaction.
Conclusions: CT venography can provide excellent road map for VV
surgery without significant complications. It cannot replace duplex USG,
but can provide powerful 3D views for designing operation as well as
education and research.
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Park, None; I.M. Jung, None; T. Lee, None; J. Ha, None; J.K. Chung,
None; S.J. Kim, None.
PP83.
Factors Affecting Post Operative Pain Following Endovenous Ablation
of Varicose Veins
Amanda C Shepherd, Manj S Gohel, Chung S Lim, Maher Hamish, Alun H
Davies. Imperial College, London, United Kingdom
Objectives: A variety of endothermal treatments are currently available
for the treatment of varicose veins, offering the prospect of less discomfort
and quicker return to normal activities compared to traditional surgery. The
aim of this study was to evaluate which factors may contribute to post-
operative pain following endothermal ablation procedures.
Methods: Patients treated with endovenous laser ablation (EVLA) or
radiofrequency ablation (RFA) completed the Aberdeen Varicose Vein
Questionnaire (AVVQ) before surgery and a 100mm visual analogue diary
card to record post-operative pain scores. Initial VCSS and CEAP scores
were assessed by a clinician and recorded along with demographic and
operative details. Independent risk factors for post-operative pain were
identified using a multivariate linear regression model.
Results: Over a 6 month period, 75 patients completed diary cards.
RFA was performed in 43/75 and EVLA in 32/75. The median (range) age
was 48 years (27-78) and 57/75 were female. Median (range) AVVQ and
VCSS scores were 17.59 (2.47-74.3) and 4 (0-13) respectively. Age, sex,
AVVQ, VCSS and CEAP scores were comparable between the treatment
groups (p0.528, 0.862, 0.186, 0.930 & 0.240 respectively, Mann Whit-
ney U test). Overall median (range) pain scores after 3 and 10 days were
20mm (1-81mm) and 17mm (1-85mm). Pain scores were significantly
higher after EVLA compared to RFA after 3 days (31mm (2-80mm) versus
16mm (1-81mm) p0.016 Mann Whitney U) and after 10 days (24 mm
(1-85mm) versus 13mm (1-68mm), p0.003 Mann Whitney U). Using a
multivariate analysis, we found that none of the other factors assessed
predicted post operative pain score at 3 days or at 10 days. Table 1. Results
of multivariate linear regression analysis (outcome - average post-operative
pain score over 3 days and 10 days).
Multivariate linear
regression analysis over 3 days
Multivariate linear
regression analysis over 10
days
Risk factor assessed HR 95% CI P value HR 95% CI P value
Male sex 0.064 (16.702-10.620) 0.657 0.065 (13.143-8.196) 0.644
Patient age 0.063 (0.532-0.346) 0.672 0.225 (0.610-0.075) 0.123
Pre-op AVVQ 0.040 (0.707-0.558) 0.814 0.071 (0.601-0.387) 0.666
Pre-op VCSS 0.256 (1.059-6.529) 0.154 0.310 (0.295-5.632) 0.077
Pre-op CEAP grade 0.066 (6.311-8.978) 0.728 0.064 (4.927-7.015) 0.727
Bilateral surgery 0.008 (12.564-13.217) 0.960 0.070 (12.350-7.786) 0.651
Total length of vein
ablated
0.072 (0.284-0.180) 0.657 0.130 (0.256-0.106) 0.410
Conclusions Pain scores were lower after RFA compared to EVLA,
however, sex, age, AVVQ, VCSS, CEAP score, bilateral intervention or the
length of vein ablated were not predictive of post operative pain.Author Disclosures: A.C. Shepherd, None; M.S. Gohel, None; C.S.
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Objective: Venous hypertension is a significant cause of patient mor-
bidity and decreased quality of life. Common etiologies of venous hyperten-
sion include deep venous thrombosis (DVT) or congenital abnormalities
resulting in chronic outflow obstruction. We have implemented an aggres-
sive endovascular approach to the treatment of iliac venous occlusion with
angioplasty and stenting. The aim of this study is to determine the patency
rates with this approach at a large tertiary care center.
Materials/Methods: All patients undergoing ilio-femoral venous an-
gioplasty and stenting over a 2 1/2 year period were identified from a
vascular surgical registry. Charts were reviewed retrospectively for patient
demographics, the extent of venous system involvement and the time course
of the venous pathology. Technical aspects of the procedure including
previous angioplasty or stenting attempts, presence of collaterals on com-
pletion venogram and stent patency were then recorded.
Results: A total of 34 patients ( 37 limbs) were stented from Jan 2005
through August 2008. Of these patients 25 were women ( 73%). Both lower
extremities were involved in 4 patients. Thrombosis was considered acute (30
days) in 13 patients (38%). The majority of patients who had a recognized
underlying etiology were diagnosed withMay-Thurner syndrome (12 patients,
48%). Mean follow-up time period in the study population was 10.5 months.
One stent in the study occluded acutely and required re-stenting. Primary
patency rates at 6, 12, and 24months were 83% (67.4, 98.6), 70% (49.3, 91.2),
and 58.5% (31.3, 85.8) respectively. Secondary patency rates for the same time
intervals were 100.0% (100.0, 100.0), 93.8% (81.9, 100.0), and 82% (58.2,
100) respectively. Although not statistically significant, external compression
and thrombophilia appear to portend less favorable outcomes.
Conclusion: Ilio-femoral venous stenting provides a safe and effective
alternative to either anti-coagulation, or open surgical bypass for the treat-
ment of iliac venous occlusive disease. Acceptable patency rates can be
expected through short-term follow-up. Further experience with this ap-
proach and longer-term follow-up is necessary.
Author Disclosures: J. Titus, None; M.A. Moise, None; S. Lyden,
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Introduction: Patients with a previous history of DVT or family
history of DVT are considered at high risk for thrombotic complications
(DVT) after endovenous ablation. In this study, we examine our outcomes
on patients presenting for “high risk” endovenous ablation.
Methods:We reviewed our vascular registry for all patients undergoing
EVA from 2006-2008. All patients were evaluated with venous ultrasonog-
raphy and initially treated with a minimum of 3 months of compression
stockings. Candidates for EVA were treated with laser ablation or radiofre-
quency ablation using a standardized technique. All patients that were
identified as potential high risk for DVT had hematology consultation and
were placed on peri-procedure anticoagulation prophylactically. Post proce-
dure ultrasound was performed at 1week, 1 month, 3 months and every 6
months thereafter for two years.
Results: A total of 685 endovenous ablations were performed (480 laser,
205 radiofrequency); the majority being greater saphenous veins. A sub-group
of patients n15(2.1%) were identified to be high risk for DVT.Mean age was
44 years. CEAP classifications ranged from 2-6, with ankle edema being the
most common diagnosis. The immediate technical success rate was 99.6%.
Access failure occurred in 3 patients (0.4%). Themost common post procedural
complications included bruising 29% (n203), phlebitis in branch varicosities
in 4% (n28) and heat induced thrombus formation in 1.9% (n13). There
was no significant difference between laser and radiofrequency groups. None of
the presumed hyper congealable patients developed thrombotic complications.
There were no mortalities in this series. Mean follow up was 6 months (range
1-27 months). Ancillary procedures were performed in 19% including stab
phlebectomy, schlerotherapy, and perforator injection or ablations. All patients
remain successfully ablated to date.
Conclusions: In our experience, EVA can be safely performed in
appropriate candidates with excellent clinical outcomes and minimal mor-
bidity and mortality. Preliminary data suggests that patients with hyperco-
agulable conditions or strong family history of thrombosis can be considered
for EVA with peri-procedural anticoagulation.
